Literature DB >> 12755371

Bacterial type III translocation: a unique mechanism for cytosolic display of heterologous antigens by attenuated Salmonella.

Holger Rüssmann1.   

Abstract

Upon infection, Gram-negative animal and plant pathogens evade the host immune response by utilizing a specialized protein secretion machinery, known as type III secretion system, for the export of bacterial virulence factors delivered directly into the cytosol of target cells. This unique translocation mechanism can be used for the delivery of large protein fragments derived from immunodominant viral and bacterial heterologous antigens into the MHC class I-restricted antigen-processing pathway by attenuated Salmonella carrier vaccines. In orally immunized mice, this novel vaccination strategy results in the induction of pronounced peptide-specific cytotoxic CD8 T cell responses.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12755371     DOI: 10.1078/1438-4221-00249

Source DB:  PubMed          Journal:  Int J Med Microbiol        ISSN: 1438-4221            Impact factor:   3.473


  11 in total

1.  Cloning and transfer of the Salmonella pathogenicity island 2 type III secretion system for studies of a range of gram-negative genera.

Authors:  James W Wilson; Clint Coleman; Cheryl A Nickerson
Journal:  Appl Environ Microbiol       Date:  2007-08-03       Impact factor: 4.792

2.  Salmonella pathogenicity island 2-mediated overexpression of chimeric SspH2 proteins for simultaneous induction of antigen-specific CD4 and CD8 T cells.

Authors:  Klaus Panthel; Katrin M Meinel; Victòria E Sevil Domènech; Heike Retzbach; Emeka I Igwe; Wolf-Dietrich Hardt; Holger Rüssmann
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

3.  RNA type III secretion signals that require Hfq.

Authors:  George S Niemann; Roslyn N Brown; Ivy T Mushamiri; Nhu T Nguyen; Rukayat Taiwo; Afke Stufkens; Richard D Smith; Joshua N Adkins; Jason E McDermott; Fred Heffron
Journal:  J Bacteriol       Date:  2013-02-08       Impact factor: 3.490

4.  Evaluation of Salmonella enterica type III secretion system effector proteins as carriers for heterologous vaccine antigens.

Authors:  Wael Abdel Halim Hegazy; Xin Xu; Leonid Metelitsa; Michael Hensel
Journal:  Infect Immun       Date:  2012-01-17       Impact factor: 3.441

5.  Superior protective immunity against murine listeriosis by combined vaccination with CpG DNA and recombinant Salmonella enterica serovar typhimurium.

Authors:  Christina Berchtold; Klaus Panthel; Stefan Jellbauer; Brigitte Köhn; Elisabeth Roider; Miriam Partilla; Jürgen Heesemann; Stefan Endres; Carole Bourquin; Holger Rüssmann
Journal:  Infect Immun       Date:  2009-09-21       Impact factor: 3.441

Review 6.  Salmonella enterica serovar Typhi live vector vaccines finally come of age.

Authors:  James E Galen; Marcela F Pasetti; Sharon Tennant; Patricia Ruiz-Olvera; Marcelo B Sztein; Myron M Levine
Journal:  Immunol Cell Biol       Date:  2009-05-05       Impact factor: 5.126

Review 7.  Type III secretion systems and disease.

Authors:  Bryan Coburn; Inna Sekirov; B Brett Finlay
Journal:  Clin Microbiol Rev       Date:  2007-10       Impact factor: 26.132

8.  Influence of promoter, gene copy number, and preexisting immunity on humoral and cellular responses to a vectored antigen delivered by a Salmonella enterica vaccine.

Authors:  Manvendra Saxena; Peter J Coloe; Peter M Smooker
Journal:  Clin Vaccine Immunol       Date:  2008-11-12

9.  Antigen-specific B cells reactivate an effective cytotoxic T cell response against phagocytosed Salmonella through cross-presentation.

Authors:  Jelle de Wit; Yuri Souwer; Tineke Jorritsma; Hanny Klaasse Bos; Anja ten Brinke; Jacques Neefjes; S Marieke van Ham
Journal:  PLoS One       Date:  2010-09-27       Impact factor: 3.240

10.  Bioinformatics analysis of the locus for enterocyte effacement provides novel insights into type-III secretion.

Authors:  Mark J Pallen; Scott A Beatson; Christopher M Bailey
Journal:  BMC Microbiol       Date:  2005-03-09       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.